H.R. 9190 · 119th Congress · Referred to the House Committee on Energy and Commerce.
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
We have not deep-analyzed this bill yet.
Here is what Congress.gov shows.
Public record
Below is the official voting record from Congress.gov. It is not our analysis.
Source: Congress.gov
This bill has no recorded roll-call vote yet. A roll-call vote records how each member voted by name.
Help keep this free. Support this work.
to get an email when it changes. Part of email alerts, $5 a month.